The FDA just approved a new drug, valbenazine, for tardive dyskinesia. Until now there have been few treatment options (vitamin E is sometimes helpful) and the most common choice patients and doctors had to make was to reduce the dose of the atypical antipsychotic that caused the tardive dyskinesia, or switch to another medication, possibly leading to worsened psychiatric symptoms. …